TONI OTELLO: Open Payments
NPI 1871522706 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$868 in 32 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $324 · 2025 $868
Food & beverage: $868
| Company | Payments | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 6 | $144 |
| Novo Nordisk Inc | 1 | $125 |
| Radius Health, Inc. | 4 | $100 |
| Lilly USA, LLC | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
| Madrigal Pharmaceuticals | 1 | $35 |
| Almatica Pharma LLC | 1 | $33 |
| Amgen Inc. | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $26 |
Products named: Yorvipath, Ozempic, Binosto, Kerendia, RECORLEV, MOUNJARO, REZDIFFRA, LOREEV XR.
Industry payments across NY — which companies pay providers there.
